Cutoff for Hypoglycemia in Newborns
Hypoglycemia in newborns should be defined as a blood glucose level below 2.5 mmol/L (45 mg/dL), with specific intervention thresholds based on clinical presentation and risk factors. 1
Definition and Diagnostic Thresholds
- A recent systematic review and meta-analysis proposes defining hypoglycemia as blood glucose levels of 2.2-2.5 mmol/L (<40-45 mg/dL) in newborns 1
- In critically ill children, hypoglycemia is defined as blood glucose below 2.8 mmol/L (50 mg/dL) or below 3.3 mmol/L (60 mg/dL) 1
- The most widely accepted definition for neonatal hypoglycemia is a blood glucose concentration below 2.6 mmol/L (47 mg/dL) 2
Intervention Thresholds
For newborns, clinicians should consider intervention at the following operational threshold concentrations:
- A single measurement of blood glucose <1 mmol/L (18 mg/dL) 1
- Blood glucose level <2 mmol/L (36 mg/dL) that remains below the same value at the next measurement 1
- A single measurement of <2.5 mmol/L (45 mg/dL) in a newborn with abnormal clinical signs 1
Risk Factors Requiring Monitoring
- Premature birth 1
- Low birth weight 1
- Perinatal asphyxia 1
- Infants of diabetic mothers, particularly those requiring insulin treatment 3
- Large for gestational age (LGA) infants 3
- Small for gestational age (SGA) infants 4
- Late preterm infants 4
Clinical Implications and Outcomes
- Repetitive and/or prolonged hypoglycemia ≤2.5 mmol/L (45 mg/dL) should be avoided in all ICU patients due to potential adverse outcomes 1
- In preterm newborns, a large cohort study reported impaired motor and cognitive development at 18 months with recurrent low blood glucose levels 1
- However, the same study found no differences in developmental progress or physical disability 15 years after recurrent low blood glucose levels (2.5 mmol/L) in the first 10 days after birth 1
- A more recent cohort study found that neonatal hypoglycemia was not associated with impaired neurological outcome at two years when treated to maintain blood glucose concentrations of at least 2.6 mmol/L (47 mg/dL) 1
Measurement Considerations
- The accuracy of handheld blood glucose meters in newborn infants is of great concern 1
- Factors that influence glucose measurements include high hemoglobin levels and high bilirubin levels 1
- Blood gas analyzers with glucose modules provide the best combination of quick results and accuracy for blood glucose measurements in newborn infants 1
Management Approach
- Newborns with risk factors for hypoglycemia require close monitoring and management of their blood glucose levels 1
- The incidence of hypoglycemia in at-risk infants can be as high as 27% 4
- For infants born to diabetic mothers, the rate of hypoglycemia on the first day of life can be high (48.6%) when using a cut-off point of ≥47 mg/dl (2.6 mmol/l) 3
- Severe hypoglycemia (<30 mg/dl or 1.7 mmol/l) occurs in approximately 4% of infants born to diabetic mothers 3
Common Pitfalls and Caveats
- There is no conclusive evidence or consensus that defines an absolute value or duration of hypoglycemia that must occur to produce neurological injury 5
- The association between hypoglycemia and mortality risk is less robust in critically ill children, as severity of illness and age may be important confounders 1
- The long-term consequences of brief periods of low glucose levels not associated with clinical signs remain uncertain 1
- Studies on the effect of hypoglycemia in the postnatal period on subsequent neurodevelopment are mostly of poor methodological quality 1
- Both overtreating and undertreating neonatal hypoglycemia carry significant potential disadvantages 6